Fintel on MSN10d
Citigroup Downgrades Quest Diagnostics (DGX)
Fintel reports that on March 4, 2025, Citigroup downgraded their outlook for Quest Diagnostics (NYSE:DGX) from Buy to Neutral ...
Yahoo Finance8d
Quest Diagnostics Incorporated (DGX)
DGX outperforms the industry and the S&P 500 ... Key Insights Using the 2 Stage Free Cash Flow to Equity, Quest Diagnostics fair value estimate is US$339 Current share... Bio-Rad witnesses growth ...
ETF Daily News18d
What is Zacks Research’s Forecast for DGX FY2025 Earnings?
Quest Diagnostics (NYSE:DGX – Get Free Report) last posted its quarterly earnings data on Thursday, January 30th. The medical research company reported $2.23 earnings per share for the quarter ...